Companies3Clinical Research

3Clinical Research

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

480

By Phase

PHASE3: 1

By Status

UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT01113775
Hover over trial bars to see details

Recent Trials

NCT01113775Collaborator
Pulmonary Embolism: Multifunctional Assessment of Prognosis
N/AUnknown
400 participants
Started: Jan 31, 2007
NCT00224588Collaborator
KETOR: Effects of Peri Operative Administration of Ketamine on Long Term Post Thoracotomy Pain
PHASE3Completed
80 participants
Started: Jan 31, 2003 · Completed: May 31, 2005
Related Companies
Parexel
acquired